Skip to content

EFFECT OF SHATPUSHPA CHURNA, DHANYAK SHUNTHI PANIYA AND AYURVEDIC DIETARY AND LIFESTYLE MODIFICATION IN MANDAGNI WITH SPECIAL REFERENCE TO SUBCLNICAL HYPOTHYROIDISM.

A RANDOMIZED COMPARATIVE CLINICAL TRIAL TO STUDY THE EFFECT OF SHATPUSHPA CHURNA, DHANYAK SHUNTHI PANIYA AND NIDANA PARIVARJAN IN MANDAGNI WITH SPECIAL REFERENCE TO SUBCLINICAL HYPOTHYROIDISM.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041594
Enrollment
40
Registered
2022-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

None listed

Sponsors

NATIONAL INSTITUTE OF AYURVEDA DEEMED TO BE UNIVERSITY JAIPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between the age of 18-60 years of either sex. 2. Patients with subclinical hypothyroidism with TSH levels ranging from 5.5µIU/ml - 20µIU/ml. 3. k/c/o Subclinical Hypothyroidism but still not taking Levothyroxine therapy. 4. Patients willing to take Ayurvedic medicine and sign the consent form. 5. Patients having symptoms of Mandagni.

Exclusion criteria

Exclusion criteria: 1. TSH level above 20 µIU/ml. 2. Patients already under Levothyroxine therapy. 3. Patients suffering from congenital hypothyroidism, overt hypothyroidism, and secondary hypothyroidism. 4. Patients of hyperthyroidism, neoplasia, toxic goitre are excluded. 5. Patients who have undergone any type of thyroid surgery. 6. Patients suffering from systemic diseases like cardiac problems, diabetes, carcinomas etc. 7. Patients taking drugs known to alter thyroid hormone level (e.g., Amiodarone) 8. Patients who are pregnant or expecting pregnancy in next six months. 9. Recent hospitalization for major illness, to exclude with ESS (Euthyroid Sick Syndrome).

Design outcomes

Primary

MeasureTime frame
Change in TSH valueTimepoint: 60 DAYS

Secondary

MeasureTime frame
Change in the symptoms of Mandagni Change in general sign and symptoms associated with subclinical hypothyroidism. Reduction in Body weight and BMI Timepoint: 60 DAYS

Countries

India

Contacts

Public ContactDR DEEP MALA

NATIONAL INSTITUTE OF AYURVEDA JAIPUR RAJASTHAN

rashmimutha21@yahoo.com7976512056

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026